Aminopeptidase a expression and enzymatic activity in primary human renal cancersNANUS, D. M; BOGENRIEDER, T; PAPANDREOU, C. N et al.International journal of oncology. 1998, Vol 13, Num 2, pp 261-267, issn 1019-6439Article

Phase I trial with pharmacokinetics analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumorsMOTZER, R. J; GULATI, S. C; TONG, W. P et al.Cancer research (Baltimore). 1993, Vol 53, Num 16, pp 3730-3735, issn 0008-5472Article

Chemotherapy for nonmetastatic osteogenic sarcoma : the memorial Sloan-Kettering experienceMEYERS, P. A; HELLER, G; HEALEY, J et al.Journal of clinical oncology. 1992, Vol 10, Num 1, pp 5-15, issn 0732-183XArticle

Differentiated thyroid cancer : Determinants of disease progression in patients <21 years of age at diagnosis : A report from the surgical discipline committee of the children's cancer groupNEWMAN, K. D; BLACK, T; HELLER, G et al.Annals of surgery. 1998, Vol 227, Num 4, pp 533-541, issn 0003-4932Article

Quality of life of women with ovarian cancerKORNBLITH, A. B; THALER, H. T; WONG, G et al.Gynecologic oncology (Print). 1995, Vol 59, Num 2, pp 231-242, issn 0090-8258Article

Advanced seminoma : treatment results, survival, and prognostic factors in 142 patientsMENCEL, P. J; MOTZER, R. J; MAZUMDAR, M et al.Journal of clinical oncology. 1994, Vol 12, Num 1, pp 120-126, issn 0732-183XArticle

Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumorsMOTZER, R. J; MADHU MAZUMDAR; GULATI, S. C et al.Journal of the National Cancer Institute. 1993, Vol 85, Num 22, pp 1828-1835, issn 0027-8874Article

Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors. Editorial commentsWOOD, D. P; HERR, H. W; HELLER, G et al.The Journal of urology. 1992, Vol 148, Num 6, pp 1812-1816, issn 0022-5347Article

Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinomaDODD, P. M; MCCAFFREY, J. A; MAZUMDAR, M et al.Cancer. 1999, Vol 85, Num 5, pp 1145-1150, issn 0008-543XArticle

A phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinomaBERG, W. J; SCHWARTZ, L. H; AMSTERDAM, A et al.Investigational new drugs. 1997, Vol 15, Num 4, pp 353-355, issn 0167-6997Article

High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors : Treatment results and prognostic factors for survival and toxicityMOTZER, R. J; MADHU MAZUMDAR; BOSL, G. J et al.Journal of clinical oncology. 1996, Vol 14, Num 4, pp 1098-1105, issn 0732-183XArticle

Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapyMURPHY, B. A; MOTZER, R. J; MADHU MAZUMDAR et al.Cancer. 1994, Vol 73, Num 10, pp 2520-2526, issn 0008-543XArticle

Prognostic factors in differentiated carcinoma of the thyroid glandSHAH, J. P; LOREE, T. R; DIGPAL DHARKER et al.The American journal of surgery. 1992, Vol 164, Num 6, pp 658-661, issn 0002-9610Conference Paper

Metastatic germ cell tumors : Modeling for response to chemotherapyBAJORIN, D. F; MAZUMDAR, M; MEYERS, M et al.Journal of clinical oncology. 1998, Vol 16, Num 2, pp 707-715, issn 0732-183XArticle

Acid phosphatase : Defining a role in androgen-independent prostate cancerSTEINECK, G; KELLY, W. K; MAZUMDAR, M et al.Urology (Ridgewood, NJ). 1996, Vol 47, Num 5, pp 719-726, issn 0090-4295Article

Chemotherapy without irradiation : A novel approach for newly diagnosed CNS germ cell tumors : results of an international cooperative trialBALMACEDA, C; HELLER, G; FINLAY, J. L et al.Journal of clinical oncology. 1996, Vol 14, Num 11, pp 2908-2915, issn 0732-183XArticle

Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma : antitumor activity in a phase II trial and interaction in vitroMOTZER, R. J; SCHWARTZ, L; LAW, T. M et al.Journal of clinical oncology. 1995, Vol 13, Num 8, pp 1950-1957, issn 0732-183XConference Paper

The effect of age at diagnosis on outcome in rhabdomyosarcomaLA QUAGLIA, M. P; HELLER, G; GHAVIMI, F et al.Cancer. 1994, Vol 73, Num 1, pp 109-117, issn 0008-543XArticle

Interferon alfa-2a in advanced renal cell carcinoma : treatment results and survival in 159 patients with long-term follow-upMINASIAN, L. M; MOTZER, R. J; GLUCK, L et al.Journal of clinical oncology. 1993, Vol 11, Num 7, pp 1368-1375, issn 0732-183XArticle

Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors : Response and survivalMCCAFFREY, J. A; MAZUMDAR, M; BAJORIN, D. F et al.Journal of clinical oncology. 1997, Vol 15, Num 7, pp 2559-2563, issn 0732-183XArticle

Phase III randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinomaLAW, T. M; MOTZER, R. J; MADHU MAZUMDAR et al.Cancer. 1995, Vol 76, Num 5, pp 824-832, issn 0008-543XArticle

Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumorsMOTZER, R. J; SHEINFELD, J; MADHU MAZUMDAR et al.Journal of clinical oncology. 1995, Vol 13, Num 11, pp 2700-2704, issn 0732-183XConference Paper

Pain in ovarian cancer patients : prevalence, characteristics, and associated symptomsPORTENOY, R. K; KORNBLITH, A. B; WONG, G et al.Cancer. 1994, Vol 74, Num 3, pp 907-915, issn 0008-543XArticle

Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancerKELLY, W. K; SCHER, H. I; MADHU MAZUMDAR et al.Journal of clinical oncology. 1993, Vol 11, Num 4, pp 607-615, issn 0732-183XArticle

Expression of basic fibroblast growth factor in primary human renal tumors : correlation with poor survivalNANUS, D. M; SCHMITZ-DRÄGER, B. J; MOTZER, R. J et al.Journal of the National Cancer Institute. 1993, Vol 85, Num 19, pp 1597-1599, issn 0027-8874Article